Retour
Prix Healios K.K. (HLOSF)
Graphique du cours de l'action HLOSF
HLOSF Dividendes
Healios K.K.
$2.1
8.8%
$0.17
À la fermeture : Jan 16, 16:00:00 GMT-5
$2.1
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$1.93
Prix d'ouverture
$2.1
Plage de la journée
$2.1 - $2.1
Plage de 52 semaines
$0.96 - $4.45
Volume
200
Volume moyen
150
BPA (TTM)
-0.39
Rendement en dividend
--
Capitalisation boursière
$242.3M
Qu’est-ce que HEALIOS K K ?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 65 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
